Cargando…
Application of CRISPR/Cas9 Technology to HBV
More than 240 million people around the world are chronically infected with hepatitis B virus (HBV). Nucleos(t)ide analogs and interferon are the only two families of drugs to treat HBV currently. However, none of these anti-virals directly target the stable nuclear covalently closed circular DNA (c...
Autores principales: | Lin, Guigao, Zhang, Kuo, Li, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661809/ https://www.ncbi.nlm.nih.gov/pubmed/26540039 http://dx.doi.org/10.3390/ijms161125950 |
Ejemplares similares
-
Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology
por: Peng, Rongxue, et al.
Publicado: (2022) -
CRISPR/Cas9 technology: applications in oocytes and early embryos
por: Zhang, Yi-ran, et al.
Publicado: (2023) -
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
por: Lin, Su-Ru, et al.
Publicado: (2014) -
Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021) -
The applications of CRISPR/Cas system in molecular detection
por: Zhou, Li, et al.
Publicado: (2018)